mortality/aging
• after adoptive transfer of diabetogenic T cells
|
immune system
• activated CD4 T cells in MOG peptide-treated mice
• after adoptive transfer of diabetogenic T cells
|
• in MOG peptide-treated mice
|
• in MOG peptide-treated mice
|
• in pancreatic T cells after adoptive transfer of diabetogenic T cells
|
• after adoptive transfer of diabetogenic T cells, mice exhibit more aggressive disease progression with earlier onset, higher mean glucose measurement and earlier lethality compared with wild-type mice
• however, the frequency of regulatory T cells is normal
|
• MOG peptide-treated mice exhibit exacerbated experimental autoimmune encephalomyelitis with increased clinical scores and absolute numbers of activated CD4 T cells, Th1 and Th17 cells
• however, the frequency of regulatory T cells is normal
|
homeostasis/metabolism
• after adoptive transfer of diabetogenic T cells
|
hematopoietic system
• activated CD4 T cells in MOG peptide-treated mice
• after adoptive transfer of diabetogenic T cells
|
• in MOG peptide-treated mice
|
• in MOG peptide-treated mice
|